Delivery Order SPE2DB24D1205-SPE2DB25FCTHU

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,567,855,737 units of the drug Clobazam 10 mg tablets, a medical treatment, with a ceiling value of $3,111.86. The contract is a firm fixed-price delivery order with an ultimate completion date of April 10, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,104,148 units of the prescription drug clobazam 10 mg tablets. The delivery order has a ceiling value of $3,644.89 and an ultimate completion date of October 16, 2024. The contract is a firm fixed-price Delivery Order, and there was no set-aside designation used. This award is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $19,133.41, is for the purchase of 4,567,156,449 units of the pharmaceutical drug Clobazam 10 mg tablets. The contract is a firm fixed-price delivery order with a completion date of February 5, 2025. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,555.93 firm fixed price delivery order is for the supply of 4,565,297,361 units of the prescription medication Clobazam 10 mg tablets. The contract has an ultimate completion date of July 31, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,555.93, is for the delivery of 4,567,841,426 units of the drug Clobazam 10 mg tablets. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement, and the ultimate completion date is April 9, 2025. The contract was awarded on April 8, 2025 and does not have a set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,565,551,084 units of the pharmaceutical product Clobazam 10 mg Tablet. The contract has a total ceiling value of $7,464.67 and a completion date of August 23, 2024. It is a firm fixed-price contract with no set-aside designation. As a major supplier of pharmaceutical products and medical supplies to the U.S. government, AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,553.76, is for the delivery of 4,566,491,621 units of the pharmaceutical drug Clobazam 10 mg tablets. This is a firm fixed-price Delivery Order contract with a period of performance through November 20, 2024. The contract does not have a set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,888,596 units of the drug clobazam 10 mg tablets. The contract has a ceiling value of $17,460.60 and a completion date of April 14, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,619.69, is for the delivery of 4,567,887,267 tablets of the drug clobazam 10 mg. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 14, 2025. The contract was awarded on April 11, 2025 and does not have a set-aside designation. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,528,749 units of the medication clobazam 10 mg tablets, with a ceiling value of $1,555.93. The contract has an ultimate completion date of November 25, 2024, and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCTHU
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,567,036,359 units of the medication Clobazam 10 mg tablets. The award has a ceiling value of $1,925.81 and an ultimate completion date of January 27, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare systems.

Generated 4/25/25, 10:14 AM